Abstract
There is currently little empirical information about attitudes towards cognitive enhancement - the use of pharmaceutical drugs to enhance normal brain functioning. It is claimed this behaviour most commonly occurs in students to aid studying. We undertook a qualitative assessment of attitudes towards cognitive enhancement by conducting 19 semi-structured interviews with Australian university students. Most students considered cognitive enhancement to be unacceptable, in part because they believed it to be unethical but there was a lack of consensus on whether it was similar or different to steroid use in sport. There was support for awareness campaigns and monitoring of cognitive enhancement use of pharmaceutical drugs. An understanding of student attitudes towards cognitive enhancement is important in formulating future policy.
Similar content being viewed by others
References
Sahakian, B.J., and S. Morein-Zamir. 2011. Neuroethical issues in cognitive enhancement. Journal of Psychopharmacology 25(2): 197–204.
Pieters, T., and S. Snelders. 2009. Psychotropic drug use: between healing and enhancing the mind. Neuroethics 2(2): 63–73.
Bostrom, N., and A. Sandberg. 2009. Cognitive enhancement: methods, ethics, regulatory challenges. Science and Engineering Ethics 15(3): 311–341.
Schermer, M. 2008. On the argument that enhancement is "cheating". Journal of Medical Ethics 34(2): 85–88.
McCabe, S.E., J.R. Knight, C.J. Teter, and H. Wechsler. 2005. Non-medical use of prescription stimulants among US college students: prevalence and correlates from a national survey. Addiction 100(1): 96–106.
Franke, A.G., C. Bonertz, M. Christmann, M. Huss, A. Fellgiebel, E. Hildt, and K. Lieb. 2011. Non-medical use of prescription stimulants and illicit use of stimulants for cognitive enhancement in pupils and students in Germany. Pharmacopsychiatry 44(2): 60–66.
Lucke, J.C., S. Bell, B. Partridge, and W.D. Hall. 2011. Deflating the Neuroenhancement Bubble. AJOB Neuroscience 2(4): 38–43.
Chatterjee, A. 2009. Is it acceptable for people to take methylphenidate to enhance performance? British Medical Journal 338: 1532–1533.
Forlini, C., and E. Racine. 2009. Autonomy and coercion in academic "cognitive enhancement" using methylphenidate: perspectives of key stakeholders. Neuroethics 2(3): 163–177.
Forlini, C., and E. Racine. 2010. Stakeholder perspectives and reactions to “academic” cognitive enhancement: unsuspected meaning of ambivalence and analogies. Public Understanding of Science. doi:10.1177/0963662510385062.
Appel, J.M. 2008. When the boss turns pusher: a proposal for employee protections in the age of cosmetic neurology. Joural of Medical Ethics 34(8): 616–618.
Schoomaker, E.B. 2007. Military medical research on cognitive performance: the warfighter's competitive edge. Aviation, Space, and Environmental Medicine. Special Issue: Operational applications of cognitive performance enhancement technologies 78(5, Sect II, Suppl): B4–B6.
Warren, O.J., D.R. Leff, T. Athanasiou, C. Kennard, and A. Darzi. 2009. The neurocognitive enhancement of surgeons: an ethical perspective. Journal of Surgical Research 152(1): 167–172.
Dees, R.H. 2007. Better brains, better selves? The ethics of neuroenhancements. Kennedy Institute of Ethics Journal 17(4): 371–395.
DeSantis, A., S.M. Noar, and E.M. Webb. 2010. Speeding through the frat house: a qualitative exploration of nonmedical ADHD stimulant use in fraternities. Journal of Drug Education 40(2): 157–171.
DeSantis, A.D., and A.C. Hane. 2010. "Adderall is definitely not a drug": justifications for the illegal use of ADHD stimulants. Substance Use & Misuse 45(1–2): 31–46.
DeSantis, A., E.M. Webb, and S.M. Noar. 2008. Illicit use of prescription ADHD medications on a college campus: a multimethodological approach. Journal of American College Health 57(3): 315–324.
Cakic, V. 2009. Smart drugs for cognitive enhancement: ethical and pragmatic considerations in the era of cosmetic neurology. Journal of Medical Ethics 35(10): 611–615.
Greely, H., B. Sahakian, J. Harris, R.C. Kessler, M. Gazzaniga, P. Campbell, and M.J. Farah. 2008. Towards responsible use of cognitive-enhancing drugs by the healthy. Nature 456(7223): 702–705.
Singh, I., and K.J. Kelleher. 2010. Neuroenhancement in young people: proposal for research, policy, and clinical management. AJOB Neuroscience 1(1): 3–16.
DeSantis, A., S.M. Noar, and E.M. Webb. 2009. Nonmedical ADHD stimulant use in fraternities. Journal of Studies on Alcohol and Drugs 70(6): 952–954.
Hansen, E.C. 2006. Successful qualitative health research. Crows Nest, NSW: Allen & Unwin.
Hill, C.E., S. Knox, B.J. Thompson, E.N. Williams, S.A. Hess, and N. Ladany. 2005. Consensual qualitative research: an update. Journal of Counseling Psychology 52(2): 196–205.
Hill, C.E., B.J. Thompson, and E.N. Williams. 1997. A guide to conducting consensual qualitative research. The Counseling Psychologist 25(4): 517–572.
Fox, N.J., and K.J. Ward. 2008. Pharma in the bedroom … and the kitchen … the pharmaceuticalisation of daily life. Sociology of Health & Illness 30(6): 856–868.
Hall, W. 2004. Feeling 'better than well:' can our experiences with psychoactive drugs help us to meet the challenges of novel neuroenhancement methods? EMBO Reports 5(12): 1105–1109.
Farah, M.J. 2002. Emerging ethical issues in neuroscience. Nature Neuroscience 5(11): 1123–1129.
Forlini, C., and E. Racine. 2009. Disagreements with implications: diverging discourses on the ethics of non-medical use of methylphenidate for performance enhancement. BMC Medical Ethics 10: 9. doi:10.1186/1472-6939-10-9.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bell, S., Partridge, B., Lucke, J. et al. Australian University Students’ Attitudes Towards the Acceptability and Regulation of Pharmaceuticals to Improve Academic Performance. Neuroethics 6, 197–205 (2013). https://doi.org/10.1007/s12152-012-9153-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12152-012-9153-9